US2009286269A1PendingUtilityA1
Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand
Est. expiryJan 20, 2024(expired)· nominal 20-yr term from priority
Inventors:Anna Benscik-ReynierAnthony William ColemanEric Da SilvaMarilyne DupinEdwige LeclereAmbroise MartinAly MoussaHerve PerronFrederic Ronzon
G01N 33/6896G01N 2800/2828
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for detecting PrP in a biological human or animal sample that may contain said PrP. The method is characterized in that it uses a molecule containing at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand selected from macrocyclic ligands and glycosaminoglycans.
Claims
exact text as granted — not AI-modified1 . A method for detecting PrP in a biological sample of human or animal origin that may contain said PrP, comprising:
a) contacting the biological sample with a molecule having at least two guanidinium and/or ammonium functions to form PrP aggregates in a reaction mixture; and b) detecting the presence of PrP.
2 . The method of claim 1 , wherein the molecule having at least two guanidinium and/or ammonium functions is selected from the group consisting of polyallylamine, triethylenetetraamine (TET), bis-3-aminopropylamine, spermine tetrahydrochloride, dihydrostreptomycin sesquisulfate, streptomycin, and salts of streptomycin.
3 . The method of claim 1 , further comprising adding proteinase K to the sample.
4 . The method of claim 1 , further comprising:
adding proteinase K to the sample to digest PrP c before (a); and detecting the presence of PrP, thereby detecting the presence of PrP res .
5 . The method of claim 1 , further comprising between (a) and (b):
separating the PrP aggregates from the reaction mixture, and denaturing the PrP aggregates.
6 . The method of claim 1 , wherein detecting the presence of PrP comprises contacting the PrP with a PrP-specific binding partner for an immunoreaction between the PrP-specific binding partner and the PrP.
7 . The method of claim 1 , wherein the molecule of (a) is streptomycin.
8 . The method of claim 1 , wherein the molecule of (a) is a salt of streptomycin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.